Dynamic Technology Lab Private Ltd Invests $813,000 in Avanos Medical, Inc. (NYSE:AVNS)

Dynamic Technology Lab Private Ltd acquired a new stake in Avanos Medical, Inc. (NYSE:AVNS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 51,056 shares of the company’s stock, valued at approximately $813,000. Dynamic Technology Lab Private Ltd owned about 0.11% of Avanos Medical at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the company. Wells Fargo & Company MN grew its holdings in Avanos Medical by 19.2% in the 4th quarter. Wells Fargo & Company MN now owns 104,830 shares of the company’s stock valued at $1,669,000 after buying an additional 16,868 shares during the period. Integrated Quantitative Investments LLC acquired a new stake in shares of Avanos Medical in the fourth quarter worth approximately $1,031,000. Pitcairn Co. grew its holdings in Avanos Medical by 13.6% in the fourth quarter. Pitcairn Co. now owns 17,290 shares of the company’s stock valued at $275,000 after purchasing an additional 2,074 shares during the period. Franklin Resources Inc. increased its position in Avanos Medical by 1.6% during the fourth quarter. Franklin Resources Inc. now owns 250,493 shares of the company’s stock worth $3,988,000 after purchasing an additional 4,065 shares during the last quarter. Finally, Norges Bank purchased a new position in Avanos Medical during the fourth quarter worth approximately $1,664,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th.

Avanos Medical Stock Performance

Shares of NYSE:AVNS opened at $13.42 on Monday. The business has a 50-day moving average of $15.48 and a two-hundred day moving average of $17.96. The firm has a market capitalization of $617.13 million, a PE ratio of 39.46 and a beta of 1.15. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical, Inc. has a 12 month low of $13.08 and a 12 month high of $25.36.

Avanos Medical (NYSE:AVNS) last posted its earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. The firm had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. As a group, research analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Insider Activity

In related news, SVP Kerr Holbrook sold 7,000 shares of the firm’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the sale, the senior vice president now directly owns 82,047 shares in the company, valued at approximately $1,251,216.75. This trade represents a 7.86 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.64% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.